[1]
Grassi, W. and Montecucco, C. 2005. Approved indications and other possible utilizations of anti-TNFa biologic drugs. Reumatismo. 57, s4 (Dec. 2005), 30–33. DOI:https://doi.org/10.4081/reumatismo.2005.4s.30.